Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A

  • Authors:
    • Wanjun Li
    • Guoyin Li
    • Zhigang Fan
    • Tao Liu
  • View Affiliations

  • Published online on: June 20, 2017     https://doi.org/10.3892/ol.2017.6426
  • Pages: 2559-2565
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Breast cancer is the most common type of malignant tumor in females, and metastasis is the most common cause of breast cancer-associated mortality. Previous studies have identified that abnormal expression of microRNAs is commonly observed in human cancer and may be crucial for cancer metastasis. In the present study, microRNA‑452 (miR‑452) was investigated for its ability to act as a tumor suppressor in breast cancer. miR‑452 expression was quantified in breast cancer tissue samples and cell lines with reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). Transwell migration and invasion assays were used to investigate the effect of miR‑452 on the migration and invasion capabilities of breast cancer cells. Potential target genes of miR‑452 were identified with miRanda and TargetScan. A luciferase reporter assay was performed to validate RAB11A as a putative target of miR‑452, and was corroborated by RT‑qPCR and western blot analyses. Finally, small interfering RNA (siRNA) was used to knockdown RAB11A expression and confirm whether miR‑452 inhibited breast cancer cell migration and invasion via the negative regulation of RAB11A. The results revealed that miR‑452 was downregulated in breast cancer tissues and cell lines, and that its downregulation may be associated with breast cancer metastasis, as miR‑452 expression inhibited the migration and invasion capacities of breast cancer cells. RT‑qPCR and western blot analyses indicated that miR‑452 negatively regulated the expression of RAB11A mRNA and protein. The luciferase reporter assay revealed that miR‑452 specifically bound to the 3'‑untranslated region of RAB11A. Furthermore, inhibition of RAB11A with siRNA inhibited breast cancer cell migration and invasion. In conclusion, the present study has demonstrated that miR‑452 may act as a tumor suppressor gene via inhibition of cell migration and invasion by targeting RAB11A in breast cancer.
View Figures
View References

Related Articles

Journal Cover

August-2017
Volume 14 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li W, Li G, Fan Z and Liu T: Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A. Oncol Lett 14: 2559-2565, 2017.
APA
Li, W., Li, G., Fan, Z., & Liu, T. (2017). Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A. Oncology Letters, 14, 2559-2565. https://doi.org/10.3892/ol.2017.6426
MLA
Li, W., Li, G., Fan, Z., Liu, T."Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A". Oncology Letters 14.2 (2017): 2559-2565.
Chicago
Li, W., Li, G., Fan, Z., Liu, T."Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A". Oncology Letters 14, no. 2 (2017): 2559-2565. https://doi.org/10.3892/ol.2017.6426